eve Conference Variant Block
- ﹡Analysis of incentive policies for industrial development strategy during the 12th five-year plan
- ﹡China and global CRO industrial trends, forecast business circumstances development
- ﹡Development prospect of China CRO industry and the cooperation between pharmaceutical enterprises and CROs
- ﹡Creating new valuable working model through strategic partnership with clients
- ﹡Bridging discovery to development in therapeutic innovation: Challenges and Solutions
- ﹡Project management during pharmaceutical preclinical R&D: Study design, facilities and data interpretation
- ﹡Dual Solutions for filing nonclinical Pharm/Tox Data in regulatory submissions to both the domestic and international agencies
Package Plan
Before 29/2/2012: USD 440
After 29/2/2012: USD 540
eve Conference Detail Testimonial
Chinese companies and academics reaching out to the western scientific community through attending meetings, publishing in scientific journals, etc is very important to address this problem. By not publishing more it is not only hurting China's growth but global growth as the opportunity to collaborate on research and find out about new discoveries is limited.
——Seth Goldenberg, President of Asia Pacific Bio Intelligence LLC
